1 day Ago By ABMN Staff
Avantor ( NYSE:AVTR – Get Free Report ) had its price target dropped by Barclays from $18.00 to $15.00 in a research note issued on Monday, MarketBeat Ratings reports.
The brokerage currently has an “overweight” rating on the stock. Barclays ‘s target price would indicate a potential upside of 18.20% from the company’s previous close.
A number of other equities analysts have also commented on AVTR. Cowen lowered shares of Avantor from a “buy” rating to a “hold” rating in a research report on Monday. Stifel Nicolaus cut Avantor from a “buy” rating to a “hold” rating and cut their price target for the company from $26.
00 to $14.00 in a research note on Monday. UBS Group restated a “neutral” rating and set a $25.
00 price objective (down previously from $29.00) on shares of Avantor in a research note on Friday, January 17th. Citigroup cut their target price on Avantor from $22.
00 to $18.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Finally, Wells Fargo & Company decreased their price target on Avantor from $25.
00 to $22.00 and set an “overweight” rating on the stock in a research report on Thursday, April 17th. Seven investment analysts have rated the stock with a hold rating and six have given a buy rating to the company.
Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $18.88.
Get Our Latest Research Report on Avantor Avantor Stock Up 1.6 % Avantor ( NYSE:AVTR – Get Free Report ) last released its quarterly earnings results on Friday, April 25th. The company reported $0.
23 earnings per share for the quarter, hitting the consensus estimate of $0.23. Avantor had a return on equity of 12.
17% and a net margin of 10.49%. The business had revenue of $1.
58 billion during the quarter, compared to analysts’ expectations of $1.61 billion. During the same period last year, the firm posted $0.
22 EPS. The firm’s revenue for the quarter was down 5.9% compared to the same quarter last year.
On average, analysts forecast that Avantor will post 1.06 earnings per share for the current year. Insiders Place Their Bets In other news, Director Joseph R.
Massaro purchased 8,100 shares of the company’s stock in a transaction dated Tuesday, April 29th. The stock was bought at an average cost of $12.30 per share, for a total transaction of $99,630.
00. Following the purchase, the director now owns 35,038 shares of the company’s stock, valued at approximately $430,967.40.
The trade was a 30.07 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website .
Also, CAO Steven W. Eck sold 4,907 shares of the business’s stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.
53, for a total value of $86,019.71. Following the sale, the chief accounting officer now owns 40,604 shares in the company, valued at $711,788.
12. This represents a 10.78 % decrease in their position.
The disclosure for this sale can be found here . Insiders own 1.20% of the company’s stock.
Institutional Trading of Avantor A number of institutional investors and hedge funds have recently bought and sold shares of the stock. MassMutual Private Wealth & Trust FSB lifted its holdings in Avantor by 99.5% during the 4th quarter.
MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after buying an additional 625 shares during the period. Smartleaf Asset Management LLC raised its position in shares of Avantor by 106.3% during the fourth quarter.
Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock worth $34,000 after acquiring an additional 830 shares during the last quarter. Wealthquest Corp acquired a new position in shares of Avantor in the first quarter worth approximately $34,000. Global Retirement Partners LLC boosted its holdings in Avantor by 76.
7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after acquiring an additional 1,067 shares during the last quarter. Finally, UMB Bank n.
a. increased its position in Avantor by 56.3% during the 4th quarter.
UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after purchasing an additional 1,074 shares during the period.
95.08% of the stock is currently owned by institutional investors and hedge funds. About Avantor ( Get Free Report ) Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. Featured Stories Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter .
.
